PsychiatriaJune 5, 2024Anna Stankiewicz, Jan Szewczyk, Julia Truszkowska et al.1 citation
Drug therapies for many psychiatric conditions do not meet patients’ expectations. New agents are being sought to treat depression and anxiety disorders, among others. Scientific interest in psychoactive substances has increased over the past few decades. Recent studies provide evidence that psychedelics may find use in the treatment of a range of mental disorders. This paper describes new...
Because psychedelics have been found to increase psychological traits like openness, mental flexibility, and interpersonal perceptiveness, some researchers believe that psychedelics could help individuals cope with the psychological effects of discrimination. However, it is still unclear whether psychedelic use can help manage the internalized stigma that deters formal mental health treatment....
Abstract Chapter 16 of Addiction Medicine covers hallucinogens, dissociative drugs, and empathogens. Hallucinogens, also termed psychedelics, are a large and diverse group of substances, some of which occur in fungi and plants and some which are chemically synthesized. Some have psychostimulant properties as well. They include psilocybin, mescaline, dimethyltryptamine (DMT), ayahuasca, lysergic...
ZUSAMMENFASSUNG Klassische Psychedelika wie Psilocybin oder Lysergsäurediethylamid (LSD) werden seit einigen Jahren wieder als Mittel für die Behandlung psychiatrischer Störungen untersucht. Nach dem Abklingen der akuten psychedelischen Effekte werden typischerweise postakute Effekte beobachtet, die eine entscheidende Rolle für den Einsatz dieser Substanzen als mögliche Therapeutika spielen und...
PsicumexJune 1, 2024Andrea Herrera Solís, Jacqueline Cortés Morelos, Alejandra E. Ruiz Contreras et al.
Los enteógenos han surgido en la investigación clínica como un tratamiento alternativo para la Depresión Resistente al Tratamiento (DRT). Tienen efectos antidepresivos rápidos y duraderos, son ansiolíticos, y mitigan la ideación suicida. Además, inducen emociones positivas y provocan experiencias místicas o espirituales, atributos que pueden contribuir a su eficacia terapéutica, dada la...
ZUSAMMENFASSUNG Die menschliche Nutzung heute als psychedelisch bezeichneter Substanzen erfolgt bereits seit Jahrtausenden. Die wissenschaftliche Untersuchung, zunächst pharmakologisch, später psychiatrisch, setzte ab Ende des 19. Jahrhunderts ein. Die ersten Überlegungen zur klinischen Anwendung insbesondere zur Unterstützung von Psychotherapien wurden ab Mitte des 20. Jahrhunderts umgesetzt...
Novel treatments are required for the 30-50% of individuals with obsessive-compulsive disorder (OCD) who remain resistant to first-line pharmacological and psychotherapeutic treatments. Recent pilot data suggest benefit from psilocybin-assisted psychotherapy (PAP) and from imagery rescripting (ImRs). We explore psychological mechanisms of change underpinning both interventions that appear to...
Recent years have seen a resurgence in randomized, placebo controlled trials (RCTs) utilizing non-classical psychedelics (e.g. 3,4-methyl enedioxy methamphetamine [MDMA]), and classical psychedelics (e.g. psilocybin, lysergic acid diethylamide [LSD], and N,N-dimethyltryptamine [DMT/ayahuasca]) in conjunction with assisted therapy (AT) for psychiatric disorders. A notable methodological...
Psychedelic substances such as lysergic acid diethylamide (LSD) and psilocybin show potential for the treatment of various neuropsychiatric disorders1-3. These compounds are thought to mediate their hallucinogenic and therapeutic effects through the serotonin (5-hydroxytryptamine (5-HT)) receptor 5-HT2A (ref. 4). However, 5-HT1A also plays a part in the behavioural effects of tryptamine...
Exploring the intricate relationship between brain's structure and function, and how this affects subjective experience is a fundamental pursuit in neuroscience. Psychedelic substances offer a unique insight into the influences of specific neurotransmitter systems on perception, cognition and consciousness. Specifically, their impact on brain function propagates across the structural...